Dave Delano

About Dave Delano

I am a visionary leader and strategic architect with over 20 years of experience at high-growth genomics and personalized medicine firms translating complex science into market-leading products. My career has been defined by bridging the gap between R&D innovation and rigorous commercial execution, building the high-performing teams, processes and infrastructure necessary for maturing organizations to scale predictably and profitably. In the current \"disciplined growth\" landscape of 2026, I focus on three core pillars of executive value:• Strategic Governance & Roadmap Acceleration: At Ambry Genetics, I orchestrated the inaugural 5-year strategic product roadmap for the company, integrating cross-functional resource alignment and project prioritization that earned a spot bonus and CEO recognition for transforming organizational long-range planning• Margin & Portfolio Optimization: I have a proven track record of driving fiscal health through portfolio audits, having successfully identified and retired low-revenue/high-effort SKUs and implemented strategic price increases to improve margins.• Customer-Centric Infrastructure: I specialize in building \"Voice of the Customer\"(VOC) ecosystems—including centralized searchable repositories—to ensure product development is guided by data-driven decisions directly informed by market demand and clinical need.Core Expertise: Product Lifecycle Management (PLM)| cross-functional team leadership | clinical diagnostics | multimodal analysis | pharmacogenomics | NGS (WGS, Exome, Transcriptome)| Product Development Process | GCLP/CLIA environments | market analysis and opportunity assessment | strategic M&A Integration

Experience

1. Senior Director Product Management Product Management and Marketing

   Ambry Genetics

   Jun 2023 — Present · Aliso Viejo, CA, US

   Led a team of 5-8 Product and Product Marketing Managers, supporting genetic testing services for healthcare providers and pharma.• Strategy & Planning: Established and led annual strategic planning process, coordinating project prioritization and resource alignment across the company, which resulted in the first formalized 5-year product roadmap. Received a spot bonus and CEO acknowledgment for this initiative.• Governance: Managed the bi-weekly Product Approval Committee (PAC) review for phase-gated Product Development Process (PDP) governance and advised Core Teams on compliance.• Commercialization: Established a formalized launch/commercialization planning process, integrating a Commercial Readiness Review into the PDP, scoping coordination across functions for optimal client experience.• Portfolio Management: Created a cross-functional portfolio audit process, reviewing financials and performance metrics to identify and coordinate end-of-life (EOL) for obsolescence candidates.• Co-led the development of a centralized, searchable Voice of Customer (VOC) repository (Salesforce application) accessible across internal and Field functions.

Education

• Washington University in St. Louis

  A.B., Biology and English Literature

  1990 — 1994

• NYU Grossman School of Medicine

  M.S., Cellular and Molecular Biology

  1996 — 1998

• NYU Grossman School of Medicine

  Ph.D., Molecular Pharmacology / Pharmacogenomics

  1998 — 2004